Scott Dodson is the CEO and President of AirXpanders. AirXpanders is an emerging medical device company to watch in the U.S. Based in Palo Alto, AirXpanders has developed a technology that improves the breast cancer reconstruction process for women and is currently under review with the FDA. By employing a revolutionary new tissue expander, the sometimes painful process of recovering one’s body from the ravages of cancer is now eased by a less painful approach which allows the patient to proceed to a permanent implant much faster and with less complications than ever before.
The company has seen strong commercial growth over the past year in Australia and is hoping to continue that momentum in the U.S. pending FDA decision. In this podcast, Scott will discuss AirXpanders’ success and how it will impact the medical device industry.